Rabbit adverse-event record

Rabbit Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 318 adverse event reports for Rabbit, distributed across 7 distinct breeds currently tracked in the system. Of those reports, 118 involved a death outcome, producing a 37.1% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Rabbit are Death (89 reports), Weight loss (32 reports), Anorexia (28 reports), Inappetence (28 reports), with Death leading the reaction traffic at 89 submissions. On the product side, Meloxicam is the single most-referenced drug with 72 reports, followed by Selamectin (67), Isoflurane (39), Imidacloprid + Moxidectin (36). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Rabbit reporting patterns against other companion animals in the dataset.

Of the 295 Rabbit reports with a coded outcome, Died accounts for the largest share at 34.6%. Annual submission volume spans 5 to 43 reports across the 17 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 7 tracked rabbit breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.